Hyperbaric oxygen therapy (HBOT) is a treatment that provides high amounts of oxygen to cellular tissue. Due to certain laws of chemistry and physics, the pressure is what differentiates this therapy from standard oxygen therapy using an oxygen tank or concentrator. Under pressure, oxygen gas is compressed into smaller molecules (Boyle’s Law) allowing concentrated amounts of oxygen to dissolve in liquid plasma. This high concentration of oxygen then travels to low areas of oxygen in the tissues (Henry’s Law). 

Multiple HBOT studies have shown that HBOT therapy decreases inflammatory markers such as c-reactive protein (CRP) and sedimentation rate (ESR). In December of 2021, the Journal of Clinical Rheumatology published a finding that rheumatoid arthritis patients who received 30 treatments over 6-10 weeks had significant improvements in pain levels and lower CRP and ESR levels.....